Descovy 200-25 MG tablet UU 30S

Ended Awarded Last action

Contract number
SPE2DR26F0BDA
Awardee
Awarding agency
Obligated
$15,797

Award facts

Contract value 100% obligated
$15,796.53 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $15,796.53 delivery order to Amerisourcebergen Drug Corp on April 16, 2026, for DESCOVY 200–25 mg tablets (30-count units). Place of performance is Conshohocken, PA. Ultimate completion date is April 17, 2026.

The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying the Department of Defense and federal healthcare systems under the DLA Troop Support Medical indefinite delivery contract structure.

Quick answers

Who was awarded contract SPE2DR26F0BDA?

SPE2DR26F0BDA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 16, 2026.

How much is contract SPE2DR26F0BDA worth?

The government has obligated $15,797 on SPE2DR26F0BDA.

Is contract SPE2DR26F0BDA an order under another contract?

Yes. SPE2DR26F0BDA is a delivery order under SPE2DR25D2206, an indefinite delivery contract.

Was contract SPE2DR26F0BDA competed?

The extent of competition for SPE2DR26F0BDA was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award